Literature DB >> 15761960

Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.

Helen Karlsson1, Per Leanderson, Christer Tagesson, Mats Lindahl.   

Abstract

High-density lipoprotein (HDL) is the most abundant lipoprotein particle in the plasma and a negative risk factor of atherosclerosis. By using a proteomic approach it is possible to obtain detailed information about its protein content and protein modifications that may give new information about the physiological roles of HDL. In this study the two subfractions; HDL(2) and HDL(3), were isolated by two-step discontinuous density-gradient ultracentrifugation and the proteins were separated with two-dimensional gel electrophoresis and identified with peptide mass fingerprinting, using matrix-assisted laser desorption/ionisation time of flight mass spectrometry. Identified proteins in HDL were: the dominating apo A-I as six isoforms, four of them with a glycosylation pattern and one of them with retained propeptide, apolipoprotein (apo) A-II, apo A-IV, apo C-I, apo C-II, apo C-III (two isoforms), apo E (five isoforms), the recently discovered apo M (two isoforms), serum amyloid A (two isoforms) and serum amyloid A-IV (six isoforms). Furthermore, alpha-1-antitrypsin was identified in HDL for the first time. Additionally, salivary alpha-amylase was identified as two isoforms in HDL(2), and apo L and a glycosylated apo A-II were identified in HDL(3). Besides confirming the presence of different apolipoproteins, this study indicates new patterns of glycosylated apo A-I and apo A-II. Furthermore, the study reveals new proteins in HDL; alpha-1-antitrypsin and salivary alpha-amylase. Further investigations about these proteins may give new insight into the functional role of HDL in coronary artery diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761960     DOI: 10.1002/pmic.200401010

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  68 in total

Review 1.  Anti-oxidant properties of high-density lipoprotein and atherosclerosis.

Authors:  Eugene A Podrez
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

2.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

3.  Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

Authors:  Tomas Vaisar; Subramaniam Pennathur; Pattie S Green; Sina A Gharib; Andrew N Hoofnagle; Marian C Cheung; Jaeman Byun; Simona Vuletic; Sean Kassim; Pragya Singh; Helen Chea; Robert H Knopp; John Brunzell; Randolph Geary; Alan Chait; Xue-Qiao Zhao; Keith Elkon; Santica Marcovina; Paul Ridker; John F Oram; Jay W Heinecke
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

4.  HDL proteomics: pot of gold or Pandora's box?

Authors:  Muredach P Reilly; Alan R Tall
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

5.  Tyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular Diels-Alder cyclization.

Authors:  Roman Shchepin; Matias N Möller; Hye-young H Kim; Duane M Hatch; Silvina Bartesaghi; Balaraman Kalyanaraman; Rafael Radi; Ned A Porter
Journal:  J Am Chem Soc       Date:  2010-11-19       Impact factor: 15.419

6.  The HDL proteome: a marker--and perhaps mediator--of coronary artery disease.

Authors:  Jay W Heinecke
Journal:  J Lipid Res       Date:  2008-12-05       Impact factor: 5.922

7.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.

Authors:  Martin Lundqvist; Johannes Stigler; Giuliano Elia; Iseult Lynch; Tommy Cedervall; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

8.  Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry.

Authors:  Lisamarie A Collins; Shama P Mirza; Ahmed H Kissebah; Michael Olivier
Journal:  Physiol Genomics       Date:  2009-11-10       Impact factor: 3.107

9.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

10.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.